The States Take the Wheel: A Roundup of Recent State Action on Psychedelics in the South

Short summary

Five Southern states advanced psychedelic-assisted therapy research through distinct policy approaches in 2025-2026. Texas seeded $50M in ibogaine trials; Mississippi and Louisiana launched state-funded programs; Georgia built regulatory infrastructure. All use federally-approved clinical pathways for opioid use disorder and PTSD treatment, contrasting decriminalization models elsewhere.

• •Texas allocated $50M in public funds for FDA-directed ibogaine clinical trials, establishing a regional template
• •Mississippi and Louisiana followed with their own settlement-funded research programs and near-unanimous legislative support
• •Georgia preemptively created regulatory rules and licensing framework for psychedelic-assisted therapy clinics

Generated with AI, which can make mistakes.